The DOI matches its Crossref record; 398 of the 412 references it cites were found in a registry or an index.
11β-Hydroxysteroid dehydrogenase type 1: a tissue specific regulator of glucocorticoid response
Abstract
11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) interconverts inactive cortisone and active cortisol. Although bidirectional, in vivo it is believed to function as a reductase generating active glucocorticoid at a prereceptor level, enhancing glucocorticoid receptor activation. In this review, we discuss both the genetic and enzymatic characterization of 11beta-HSD1, as well as describing its role in physiology and pathology in a tissue-specific manner. The molecular basis of cortisone reductase deficiency, the putative "11beta-HSD1 knockout state" in humans, has been defined and is caused by intronic mutations in HSD11B1 that decrease gene transcription together with mutations in hexose-6-phosphate dehydrogenase, an endoluminal enzyme that provides reduced nicotinamide-adenine dinucleotide phosphate as cofactor to 11beta-HSD1 to permit reductase activity. We speculate that hexose-6-phosphate dehydrogenase activity and therefore reduced nicotinamide-adenine dinucleotide phosphate supply may be crucial in determining the directionality of 11beta-HSD1 activity. Therapeutic inhibition of 11beta-HSD1 reductase activity in patients with obesity and the metabolic syndrome, as well as in glaucoma and osteoporosis, remains an exciting prospect.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Cortisone and prednisone are inactive prohormones that must be reduced to cortisol or prednisolone by hepatic 11HSD1 to bind to and activate the glucocorticoid receptor (GR) (45, 587).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [587]
In the citing paper
“other health outcomes associated with better quality of life improved, including sleep apnoea136 and mobility137.”
From Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future (2014) · cites this paper as [136]
In the citing paper
“the glucocorticoid sensitivity may be different among the different individuals and among the different tissues in the same individual, due also to polymorphisms of both glucocorticoid receptor (25)(26)(27)(28) and 11-hydroxysteroid-dehydrogenase type 1 genes (29,30).”
From Diagnosis and Treatment of Subclinical Hypercortisolism (2011) · cites this paper as [29]
In the citing paper
“HSD11B2 functions exclusively as an oxidative enzyme, inactivating cortisol to cortisone [108].”
From Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: a comprehensive review (2019) · cites this paper as [108]
In the citing paper
“while 17OHP and cortisol can be either 5α- or 5β-reduced, 11-deoxycortisol and cortisone are predominantly 5β-reduced [108].”
From Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: a comprehensive review (2019) · cites this paper as [108]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Sapolsky, R. M., Romero, L. M., & Munck, A. U. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.1.0389 · Cited by 7,541 · cited 1×
“Immunomodulation represents an important facet of glucocorticoid physiology and inflammation therapy and is manifested by the regulation of cytokine production and immune cell function (324).”
Sapolsky, R. M. (2000) · Endocrine Reviews · doi:10.1210/er.21.1.55 · Cited by 7,533
A transgenic model of visceral obesity and the metabolic syndrome
Masuzaki, H., Paterson, J., Shinyama, H., Morton, N. M., Mullins, J. J., Seckl, J. R., & Flier, J. S. (2001) · Science · doi:10.1126/science.1066285 · Cited by 1,766 · cited 1×
“Mice overexpressing 11 -HSD1 under the aP2 promoter have enhanced adipocyte differentiation (as measured by increased fat cell size) as a consequence of increased adipose tissue corticosteroid concentrations (139) (see Section VII.”
Short-chain dehydrogenases/reductases (SDR)
Jörnvall, H., Persson, B., Krook, M., Atrian, S., Gonzalez-Duarte, R., Jeffery, J., & Ghosh, D. (1995) · Biochemistry · doi:10.1021/bi00018a001 · Cited by 1,249 · cited 3×
“Also known as short-chain alcohol dehydrogenases (35) or sec (secondary) alcohol dehydrogenases (36), members of this family were originally classified as having 250–300 residues (classical family) with an N-terminal cofactor-binding domain and a centrally located active site, although some enzymes now have more than…”
Edwards, C. R. W., Burt, D., Mcintyre, M. A., De Kloet, E. R., Stewart, P. M., Brett, L., Sutanto, W. S., & Monder, C. (1988) · The Lancet · doi:10.1016/s0140-6736(88)90742-8 · Cited by 1,068
Self-citationCole, T. J., Blendy, J. A., Monaghan, A. P., Krieglstein, K., Schmid, W., Aguzzi, A., Fantuzzi, G., Hummler, E., Unsicker, K., & Schütz, G. (1995) · Genes & Development · doi:10.1101/gad.9.13.1608 · Cited by 946 · cited 1×
“Within the fetal rat lung, corticosteroids increased 11-oxoreductase activity, which in turn resulted in an increase in surfactant synthesis (71), a glucocorticoiddependent process (336) essential for normal lung maturation.”
Impaired Energy Homeostasis in C/EBPα Knockout Mice
Wang, N.-D., Finegold, M. J., Bradley, A., Ou, C. N., Abdelsayed, S. V., Wilde, M. D., Taylor, L. R., Wilson, D. R., & Darlington, G. J. (1995) · Science · doi:10.1126/science.7652557 · Cited by 929
Kotelevtsev, Y., Holmes, M. C., Burchell, A., Houston, P. M., Schmoll, D., Jamieson, P., Best, R., Brown, R., Edwards, C. R. W., Seckl, J. R., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14924 · Cited by 858
Stewart, P., Valentino, R., Wallace, A. M., Burt, D., Shackleton, C. L., & Edwards, C. W. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91014-2 · Cited by 803
Self-citationANTI-ESCHERICHIA COLI ALPHA-HAEMOLYSIN IN CONTROL AND PATIENT SERA
Emody, L., Batai, I., Kerényi, M., Székely, J., & Polyak, L. (1982) · The Lancet · doi:10.1016/s0140-6736(82)90183-0 · Cited by 800
Research works printed but not linked: 6
- Bush, 1969, 11β-Hydroxysteroid dehydrogenase: contrast between studies in vivo and studies in vitro., Adv Biosci, 3, 23
- Taylor, 1990, Corticosteroid 11-reductase deficiency: steroid studies in a further family, J Clin Invest, 13, P238
- Burtt, 2003, Haplotype-based association studies of HSD11B1 and abdominal obesity, 117
- Bujalska, 2000, Glucocorticoids, 11β-hydroxysteroid dehydrogenase and obesity, 158
- Taylor, 1984, Cortisone reductase deficiency: evidence for a new inborn error in metabolism of adrenal steroids, J Endocrinol, 102, 89
- Savage, 1991, Increased metabolic clearance of cortisol in corticosteroid 11-reductase deficiency, J Endocrinol, 129, 219
Cited by
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
Miller, W. L., & Auchus, R. J. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0013 · Cited by 2,458
Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future
Kahn, S. E., Cooper, M. E., & Del Prato, S. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62154-6 · Cited by 1,743
Self-citationGlucocorticoid-induced osteoporosis: pathophysiology and therapy
Canalis, E., Mazziotti, G., Giustina, A., & Bilezikian, J. P. (2007) · Osteoporosis International · doi:10.1007/s00198-007-0394-0 · Cited by 1,114
“11β-hydroxysteroid dehydrogenases regulate the interconversion between cortisone and hormonally active cortisol, and play a role in the regulation of glucocorticoid activity [72].”
Frailty and sarcopenia: The potential role of an aged immune system
Wilson, D., Jackson, T., Sapey, E., & Lord, J. M. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2017.01.006 · Cited by 573
“11 HSD1 activity increases with age and is induced by cytokines including TNF and IL-6 (Tomlinson et al., 2004).”
Interactions between sleep, stress, and metabolism: From physiological to pathological conditions
Hirotsu, C., Tufik, S., & Andersen, M. L. (2015) · Sleep Science · doi:10.1016/j.slsci.2015.09.002 · Cited by 495
“[111] Tomlinson JW, Walker EA, Bujalska IJ, Draper N, Lavery GG, Cooper MS, et al.”
Metadata
- Authors
- Tomlinson, J. W., Walker, E. A., Bujalska, I. J., Draper, N., Lavery, G. G., Cooper, M. S., Hewison, M., & Stewart, P. M.
- Affiliations
- Queen Elizabeth Hospital Birmingham (GB)
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2004-10-01
- Volume
- 25
- Issue
- 5
- Pages
- 831-866
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2016125985
- Semantic Scholar
- 7653c899826b606d61172864887c634e9d76851b
- Cited by
- 969
- References
- 412
- Citations by year
- 2026: 17 · 2025: 22 · 2024: 25 · 2023: 23 · 2022: 32 · 2021: 30 · 2020: 27 · 2019: 34 · 2018: 30 · 2017: 33 · 2016: 38 · 2015: 43 · 2014: 55 · 2013: 65 · 2012: 70
- FWCI
- 7.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- 11β-hydroxysteroid dehydrogenase type 1, glucocorticoid metabolism, hexose-6-phosphate dehydrogenase, NADPH cofactor, tissue-specific gene regulation, obesity, metabolic syndrome, glaucoma, osteoporosis, 11β-HSD1 inhibition
- MeSH terms
- Amino Acid Sequence, Animals, Carbohydrate Dehydrogenases, Cloning, Molecular, Cortisone Reductase, Enzyme Inhibitors, Glaucoma, Glucocorticoids, Humans, Hydrocortisone, Molecular Sequence Data, Mutation, NADP, Obesity, Organ Specificity, Osteoporosis, Recombinant Proteins, Substrate Specificity, Transcription, Genetic, Gene Expression Regulation, Enzymologic, Sequence Alignment, 11-beta-Hydroxysteroid Dehydrogenase Type 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: 11β-Hydroxysteroid dehydrogenase type 1: a tissue specific regulator of glucocorticoid response. https://app.cochat.ai/papers/10.1210/er.2003-0031
- The paper
- Tomlinson, J. W., Walker, E. A., Bujalska, I. J., Draper, N., Lavery, G. G., Cooper, M. S., Hewison, M., & Stewart, P. M. (2004). 11β-Hydroxysteroid dehydrogenase type 1: a tissue specific regulator of glucocorticoid response. Endocrine Reviews. https://doi.org/10.1210/er.2003-0031
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.